Información:
Error:
ID
18447
Descripción
Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00239291
Link
https://clinicaltrials.gov/show/NCT00239291
Palabras clave
Versiones (1)
- 5/11/16 5/11/16 -
Subido en
5 de noviembre de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Non-Metastatic Prostate Cancer NCT00239291
Eligibility Non-Metastatic Prostate Cancer NCT00239291
- StudyEvent: Eligibility
Similar models
Eligibility Non-Metastatic Prostate Cancer NCT00239291
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Prostate carcinoma Localized | Prostate carcinoma Advanced Locally | TNM clinical staging | Biopsy
Item
biopsy confirmation of localised (t2) or locally advanced (t3) prostate cancer
boolean
C0600139 (UMLS CUI [1,1])
C0392752 (UMLS CUI [1,2])
C0600139 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C3258246 (UMLS CUI [3])
C0005558 (UMLS CUI [4])
C0392752 (UMLS CUI [1,2])
C0600139 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C3258246 (UMLS CUI [3])
C0005558 (UMLS CUI [4])
Prostate specific antigen measurement
Item
psa below 20 ng/ml
boolean
C0201544 (UMLS CUI [1])
Negative Lymph Node
Item
lymph node negative
boolean
C0678034 (UMLS CUI [1])
Metastatic
Item
non-metastatic
boolean
C0036525 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Prostate carcinoma Well Differentiated | TNM clinical staging | Gleason score
Item
well differentiated stage t2 prostate cancer (gleason score 2 to 4)
boolean
C0600139 (UMLS CUI [1,1])
C0205615 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
C3203027 (UMLS CUI [3])
C0205615 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
C3203027 (UMLS CUI [3])
Neoplasm Metastasis Distant | Neoplasm Metastasis nodal
Item
distant or nodal metastases
boolean
C0027627 (UMLS CUI [1,1])
C0443203 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C0443268 (UMLS CUI [2,2])
C0443203 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C0443268 (UMLS CUI [2,2])
Prostatectomy
Item
prostatectomy
boolean
C0033573 (UMLS CUI [1])
Luteinizing Hormone-releasing Hormone Agonist
Item
concomitant lhrh analog treatment
boolean
C1518041 (UMLS CUI [1])
Androgen Antagonists
Item
previous or concomitant anti-androgens
boolean
C0002842 (UMLS CUI [1])
Lung Diseases, Interstitial
Item
active ild
boolean
C0206062 (UMLS CUI [1])